Manganese-based nanoflower capable of inducing pyroptosis of tumor cells as well as preparation method and application of manganese-based nanoflower
Manganese-based nanoflowers address the specificity and side effect issues of current pyroptosis inducers by inducing tumor cell pyroptosis, enhancing anti-tumor immunity and providing a safe, effective treatment option.
Patent Information
- Application Number
- CN202411243237.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-05
- Publication Date
- 2024-12-06
AI Technical Summary
Current drugs that induce pyroptosis in tumor cells suffer from poor specificity and significant side effects, limiting their effectiveness in tumor treatment.
A manganese-based nanoflower that induces pyroptosis in tumor cells, prepared through a simple process involving potassium permanganate and oleic acid, which is used as a drug carrier to promote anti-tumor immunity.
The manganese-based nanoflowers effectively induce pyroptosis, releasing inflammatory factors to enhance anti-tumor immunity, with high anti-tumor activity and good safety, suitable for use in tumor immunotherapy and potentially other biomedical applications.
Smart Images

Figure CN119074765A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedical nanomaterials, and specifically relates to a manganese-based nanoflower capable of inducing pyroptosis of tumor cells, and a preparation method and application thereof. Background Art
[0002] In recent years, the field of tumor immunotherapy is still faced with the problem that some tumors have low immunogenicity and tumor patients have low responsiveness to immunotherapy. Immunogenic cell death (ICD) is a promising method to activate the immunogenicity of tumor cells to enhance anti-tumor immune response. In this process, tumor cells secrete immunostimulatory damage-associated molecular patterns (DAMPs), including surface-exposed calreticulin (CRT), high-mobility group protein B1 (HMGB1) and adenosine triphosphate (ATP), and have the ability to promote T cell infiltration in tumor tissues, thereby converting immune-cold tumors into hot tumors. Inducing tumor cells to undergo ICD has become a new and effective strategy in tumor treatment. ICD includes multiple forms of cell death, and the currently recognized immunogenic forms of death are mainly pyroptosis, necroptosis and ferroptosis.
[0003] Pyroptosis is a form of programmed cell death mediated by a family of perforating proteins, Gasdermin (GSDM). Existing research results show that the inhibitory effect of the C-terminus of the GSDM protein on the N-terminus makes the full-length GSDM protein in a self-inhibited state, and cells will not undergo pyroptosis under normal circumstances. When cells are stressed by changes in external conditions, the GSDM protein is cleaved by proteases to release its N-terminal domain with perforating activity, which is then transported to the cell membrane to form pores, resulting in changes in cell membrane permeability, and ultimately causing the cell to rupture and release intracellular inflammatory substances, including calreticulin (CRT), high-mobility group protein B1 (HMGB1) and ATP and other cell contents, which can activate the body's immune response and improve the immune microenvironment, inhibiting tumor growth, and therefore plays an important role in tumor treatment.
[0004] However, the current drugs that induce pyroptosis in tumor cells face the problems of poor specificity and large side effects. There is an urgent need to explore pyroptosis inducers that can specifically induce pyroptosis and have good safety. Nanomaterials are adjustable in size, and the appropriate particle size can promote their selective aggregation in draining lymph nodes, efficiently target tumor tissues, and have good safety. These advantages also make nanomaterials increasingly widely used in the biomedical field. As a new type of biomedical nanomaterial, manganese-based nanoflowers have shown great application potential in tumor diagnosis, treatment and imaging due to their unique physical and chemical properties and biosafety. However, there are currently few reports on the application of manganese-based nanoflowers in inducing pyroptosis in tumor cells.
[0005] To this end, those skilled in the art have proposed a manganese-based nanoflower that can induce tumor cell pyroptosis and a preparation method and application thereof to solve the problems raised by the background technology. Summary of the invention
[0006] In order to solve the above technical problems, the present invention provides a manganese-based nanoflower that can induce tumor cell pyroptosis and a preparation method and application thereof, so as to solve the problems of poor specificity and large side effects faced by the current drugs that induce tumor cell pyroptosis in the prior art.
[0007] A manganese-based nanoflower that can induce pyroptosis of tumor cells. The nanomaterial has a simple composition, is not loaded with drugs, and can be used as a drug carrier, referred to as NF.
[0008] A method for preparing manganese-based nanoflowers that can induce tumor cell pyroptosis, comprising the following steps: dissolving 0.1 g of potassium permanganate in 50 mL of distilled water, and rapidly stirring the mixture for about 0.5 h; adding 1 mL of oleic acid, and reacting the resulting mixture for 6 h; thereafter, collecting a crude brown-black product by centrifugation at 12,000 rpm, and washing it several times with deionized water and ethanol to remove any possible residual reactants; dissolving the final product in deionized water, and centrifuging it at 2,000 rpm to remove coarse particles; collecting the supernatant, and obtaining the final product by centrifugation at 12,000 rpm.
[0009] According to the above-mentioned manganese-based nanoflowers, they are used in inhibiting tumor cell proliferation, inducing tumor cell pyroptosis and inhibiting tumor growth.
[0010] Compared with the prior art, the present invention has the following beneficial effects:
[0011] The manganese-based nanoflowers of the present invention can be used as an inducer of pyroptosis to release inflammatory factors that can promote anti-tumor immunity. The preparation process of manganese-based nanoflowers is simple, the conditions are mild, they are easy to mass produce, and they have high anti-tumor activity and good safety. The above advantages are beneficial to the application of the nanomaterial in the field of tumor immunotherapy, and can be used in combination with existing immunotherapy or targeted drugs to further improve the treatment effect. At the same time, with the continuous development of nanotechnology and biomedicine technology, the nanomaterial is expected to be used in more fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 Schematic diagram of the morphology of the manganese-based nanoflower of the present invention;
[0013] Figure 2 Schematic diagram of the research on the proliferation inhibition of Yumm5.2 and A375 cells by manganese-based nanoflowers of the present invention;
[0014] Figure 3Schematic diagram of the study on the cell death of Yumm5.2 and A375 cells by manganese-based nanoflowers of the present invention;
[0015] Figure 4 Schematic diagram of the morphological characteristics of Yumm5.2 and A375 cell death induced by manganese-based nanoflowers of the present invention (the arrows indicate pyroptotic vacuoles);
[0016] Figure 5 This is a schematic diagram of the effect of the manganese-based nanoflowers of the present invention on inhibiting tumor growth in vivo;
[0017] Figure 6 It is a schematic diagram of the effect of the manganese-based nanoflowers of the present invention on inducing immunogenic death in vivo;
[0018] Figure 7 Schematic diagram showing the effects of different cell death inhibitors of the present invention on the cell death induced by manganese-based nanoflowers in Yumm5.2 and A375 cells;
[0019] Figure 8 Schematic diagram of the effect of the manganese-based nanoflowers of the present invention on pyroptosis execution proteins in Yumm5.2 and A375 cells. DETAILED DESCRIPTION
[0020] The following embodiments of the present invention are described in further detail in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
[0021] Embodiment: The present invention provides a manganese-based nanoflower that can induce pyroptosis of tumor cells. The nanomaterial has simple components, is not loaded with drugs, and can be used as a drug carrier, referred to as NF.
[0022] The technical scheme is as follows: Preparation of manganese-based nanoflowers: 0.1 g potassium permanganate is dissolved in 50 mL distilled water, and the mixture is rapidly stirred for about 0.5 h; 1 mL oleic acid is added, and the resulting mixture is reacted for 6 h; thereafter, a crude brown-black product is collected by centrifugation at 12000 rpm, and washed several times with deionized water and ethanol to remove any possible residual reactants; the final product is dissolved in deionized water, and centrifuged at 2000 rpm to remove coarse particles; the supernatant is collected, and the final product (such as Figure 1 shown).
[0023] The application of the manganese-based nanoflowers prepared above will be further described below in conjunction with specific application examples.
[0024] Application Example 1: Effects of manganese-based nanoflowers on tumor cell proliferation and cytotoxicity in vitro: Yumm5.2 and A375 cell lines were selected to monitor the effects of manganese-based nanoflowers on tumor cell proliferation and cytotoxicity. 3Yumm5.2 and A375 cells were inoculated in 96-well plates and cultured overnight. After being treated with manganese-based nanoflowers (0, 1, 10, 20, 50 μg / mL) for 48 h, the cell viability was detected using the CCK8 method, and the absorbance OD value was measured by an ELISA reader at a wavelength of 450 nm; cell viability = [OD (drug added) - OD (blank)] / [OD (control) - OD (blank)] * 100%; the experimental results are shown in Figure 2 As shown, with the increase of the concentration of manganese-based nanoflowers, the cell proliferation of Yumm5.2 and A375 was significantly inhibited.
[0025] Application Example 2: Effect of manganese-based nanoflowers on tumor cell death in vitro: Yumm5.2 and A375 cell lines were selected to monitor the effect of manganese-based nanoflowers on tumor cell death. 4 Yumm5.2 was inoculated in a 24-well plate and cultured overnight. It was treated with manganese-based nanoflowers (0, 25, 50, 100 μg / mL) for 48 h. 4 A375 cells were inoculated in 24-well plates and cultured overnight. They were treated with manganese-based nanoflowers (0, 1, 10, 20, 50 μg / mL) for 48 h. The culture supernatant and cells in the well plates were collected and centrifuged at 1500 rpm for 5 min. The supernatant was discarded and stained with propidium iodide (PI) dye for 15 min before flow cytometry detection. The results are shown in Figure 2. Figure 3 As shown, the increase in the concentration of manganese-based nanoflowers led to the death of Yumm5.2 and A375 cells.
[0026] Application Example 3: Effect of manganese-based nanoflowers on tumor cell morphology in vitro: 2X10 4 Yumm5.2 and A375 cells were inoculated in 24-well plates and cultured overnight, and treated with manganese-based nanoflowers (0, 20 μg / mL) for 48 h. Microscope imaging was used to observe the morphological characteristics of tumor cells after treatment with manganese-based nanoflowers. Figure 4 As shown, tumor cells showed morphological characteristics of pyroptotic vacuoles after treatment with manganese-based nanoflowers.
[0027] Application Example 4: Effect of manganese-based nanoflowers on inhibiting tumor growth in vivo: C57BL / 6 mice aged 6-8 weeks were purchased and 2X10 5 Yumm5.2 cells were treated by tail vein injection of 5 mg / kg manganese-based nanoflowers on the 6th, 8th, 10th, and 12th days after inoculation. The tumor volume of mice was monitored regularly to draw a tumor growth curve. The experiment was terminated on the 34th day, and the tumor tissues of mice were taken for photography and weighing. The results are as follows Figure 5 As shown, treatment with manganese-based nanoflowers can significantly inhibit the tumor volume and reduce tumor weight in mice, and has the effect of inhibiting tumor growth.
[0028] Application Example 5: Effect of manganese-based nanoflowers in inducing immunogenic death in vivo: C57BL / 6 mice aged 6-8 weeks were purchased, and Yumm5.2 cells that died after being treated with manganese-based nanoflowers were first subcutaneously inoculated in the left lower limb of the mice. Two weeks later, live Yumm5.2 cells were subcutaneously inoculated in the right lower limb of the mice. The tumor volume of the mice was regularly monitored to draw a tumor growth curve. The experiment was terminated on the 27th day, and the tumor tissues of the mice were taken for photographing and weighing; the results are as follows Figure 6 As shown, early inoculation of dead Yumm5.2 cells can inhibit tumor growth, indicating that cell death induced by manganese-based nanoflowers is immunogenic.
[0029] Application Example 6: Cell death inhibitor verifies the cell death form induced by manganese-based nanoflowers: 2X10 4 Yumm5.2 and A375 cells were inoculated in 24-well plates and cultured overnight. Different cell death inhibitors were added, including IDN (40 μM), Nec-1 (40 μM), NSA (1 μM), GSK (3 μM), and Fer-1 (5 μM). IDN is a pan-caspase inhibitor that can inhibit pyroptosis and apoptosis. Nec-1, NSA and GSK are necroptosis inhibitors, and Fer-1 is a ferroptosis inhibitor. After treatment with different cell death inhibitors for 1 hour, manganese-based nanoflowers (20 μg / mL) were added for 48 hours. The culture supernatant and cells in the well plate were collected, centrifuged at 1500 rpm for 5 minutes, and the supernatant was discarded. The cells were stained with propidium iodide (PI) dye for 15 minutes and then detected by flow cytometry. The results are shown in Figure 2. Figure 7 As shown, only IDN, an apoptosis / pyroptosis inhibitor, can significantly inhibit cell death induced by manganese-based nanoflowers, while necroptosis inhibitors and ferroptosis inhibitors cannot inhibit cell death induced by manganese-based nanoflowers.
[0030] Application Example 7: Verify the effect of manganese-based nanoflowers on cell pyroptosis executive proteins: Yumm5.2 cells were seeded in 6-well plates, and proteins were extracted after treatment with manganese-based nanoflowers (20 μg / mL) for 0, 24, and 48 hours. After electrophoresis and transfer, antibodies to pyroptosis-related proteins (Caspase3 and GSDME) were incubated, and imaging was performed using a chemiluminescence imaging system. The experimental results are shown in the figure. Figure 8 As shown, after treatment with manganese-based nanoflowers, two bands appeared in Caspase3, and two bands appeared in GSDME, a marker of cell pyroptosis. The N-terminus of the GSDME protein (GSDME-N) has membrane perforation activity, thereby destroying the cell membrane and inducing cell pyroptosis. The above results show that manganese-based nanoflowers induce pyroptosis in tumor cells.
[0031] From the above, it can be seen that the manganese-based nanoflowers of the present invention can induce tumor cell pyroptosis, serve as an inducer of tumor cell pyroptosis, and have the effect of inhibiting tumor growth.
[0032] In summary, the present invention found that manganese-based nanoflowers can be used as inducers of pyroptosis to release inflammatory factors that can promote anti-tumor immunity. The preparation process of manganese-based nanoflowers is simple, the conditions are mild, they are easy to mass produce, and they have high anti-tumor activity and good safety. The above advantages are beneficial to the application of this nanomaterial in the field of tumor immunotherapy, and can be used in combination with existing immunotherapy or targeted drugs to further improve the treatment effect. At the same time, with the continuous development of nanotechnology and biomedicine technology, this nanomaterial is expected to be used in more fields.
[0033] The embodiments of the present invention are provided for the purpose of illustration and description. Although the embodiments of the present invention have been shown and described above, it can be understood that the above embodiments are exemplary and cannot be understood as limitations of the present invention. Ordinary technicians in this field can change, modify, replace and modify the above embodiments within the scope of the present invention.
Claims
1. A manganese-based nanoflower that can induce pyroptosis of tumor cells, characterized in that: The manganese-based nanoflower is a nanomaterial with simple components, no loaded drugs, and can be used as a drug carrier.
2. A method for preparing a manganese-based nanoflower capable of inducing tumor cell pyroptosis as claimed in claim 1, characterized in that: The following steps are involved: S1. Dissolve 0.1 g potassium permanganate in 50 mL distilled water and stir rapidly for about 0.5 hours; S2, add 1 mL of oleic acid and react for 6 hours; S3, centrifuge at 12000 rpm to collect the crude brown-black product, and wash it several times with deionized water and ethanol; S4, dissolving the product in deionized water, centrifuging at 2000 rpm to remove coarse particles, and collecting the supernatant; S5. Finally, centrifuge at 12000 rpm to obtain the final product.
3. The application of a manganese-based nanoflower that can induce tumor cell pyroptosis in inhibiting tumor cell proliferation, inducing tumor cell pyroptosis and inhibiting tumor growth.
